STERIS (STE)
(Delayed Data from NYSE)
$239.46 USD
+1.08 (0.45%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $239.57 +0.11 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
STE 239.46 +1.08(0.45%)
Will STE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for STE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STE
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?
Reasons to Retain STERIS Stock in Your Portfolio for Now
STE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Don't Overlook Steris (STE) International Revenue Trends While Assessing the Stock
STERIS (STE) Q1 Earnings Beat Estimates, Operating Margin Falls
Steris (STE) Reports Q1 Earnings: What Key Metrics Have to Say
Other News for STE
Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Dividend Champion, Contender, And Challenger Highlights: Week Of September 15
Steris PLC (STE) Shares Down 2.95% on Sep 11
Election 2024: Where To Put Your Money Ahead of the Vote
Steris Market Position and Outlook: A Hold Recommendation